chr2-151727817-T-TGCTGGCTGTGCCAGA

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001164507.2(NEB):​c.153_167dupTCTGGCACAGCCAGC​(p.Ala56_Leu57insLeuAlaGlnProAla) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,604,630 control chromosomes in the GnomAD database, including 15 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A56A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00062 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 14 hom. )

Consequence

NEB
NM_001164507.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.768

Publications

0 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001164507.2
BP6
Variant 2-151727817-T-TGCTGGCTGTGCCAGA is Benign according to our data. Variant chr2-151727817-T-TGCTGGCTGTGCCAGA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 419871.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000622 (92/147970) while in subpopulation SAS AF = 0.0116 (56/4826). AF 95% confidence interval is 0.00918. There are 1 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 14 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001164507.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEB
NM_001164507.2
MANE Plus Clinical
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 182NP_001157979.2
NEB
NM_001164508.2
MANE Select
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 182NP_001157980.2
NEB
NM_001271208.2
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 183NP_001258137.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEB
ENST00000397345.8
TSL:5 MANE Select
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 182ENSP00000380505.3
NEB
ENST00000427231.7
TSL:5 MANE Plus Clinical
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 182ENSP00000416578.2
NEB
ENST00000409198.5
TSL:5
c.153_167dupTCTGGCACAGCCAGCp.Ala56_Leu57insLeuAlaGlnProAla
disruptive_inframe_insertion
Exon 5 of 150ENSP00000386259.1

Frequencies

GnomAD3 genomes
AF:
0.000615
AC:
91
AN:
147858
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000793
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000729
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0114
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000325
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00154
AC:
379
AN:
246372
AF XY:
0.00197
show subpopulations
Gnomad AFR exome
AF:
0.0000713
Gnomad AMR exome
AF:
0.000176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000468
Gnomad NFE exome
AF:
0.000392
Gnomad OTH exome
AF:
0.000500
GnomAD4 exome
AF:
0.00119
AC:
1736
AN:
1456660
Hom.:
14
Cov.:
31
AF XY:
0.00147
AC XY:
1062
AN XY:
724714
show subpopulations
African (AFR)
AF:
0.0000622
AC:
2
AN:
32170
American (AMR)
AF:
0.000180
AC:
8
AN:
44538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0107
AC:
927
AN:
86234
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53254
Middle Eastern (MID)
AF:
0.00193
AC:
11
AN:
5696
European-Non Finnish (NFE)
AF:
0.000645
AC:
715
AN:
1108826
Other (OTH)
AF:
0.00120
AC:
72
AN:
60134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
89
178
267
356
445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000622
AC:
92
AN:
147970
Hom.:
1
Cov.:
32
AF XY:
0.000760
AC XY:
55
AN XY:
72390
show subpopulations
African (AFR)
AF:
0.0000791
AC:
3
AN:
37934
American (AMR)
AF:
0.000728
AC:
11
AN:
15100
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0116
AC:
56
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10504
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
0.000325
AC:
22
AN:
67692
Other (OTH)
AF:
0.00
AC:
0
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000304
Hom.:
0
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: PM4, BS1, BS2

Sep 12, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 19, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 30, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nemaline myopathy 2 Benign:3
Jun 10, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 05, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 06, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.77
Mutation Taster
=87/13
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757726895; hg19: chr2-152584331; COSMIC: COSV51471118; API